Skip to content
ppharmaranks
Menu
Class IIOngoing

Furosemide Tablets recall

FDA recall D-0486-2026 · initiated Mar 20, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 29, 2026How we research

Leading Pharma, LLC recalled Furosemide Tablets in Mar 2026 — an FDA Class II recall (D-0486-2026) because CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

An impurity above the accepted limit

A by-product of manufacturing or storage exceeded the limit the FDA accepts. Nitrosamines are the common example: the concern is long-term exposure, not immediate danger from one dose.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lots# H03125, H03225, H03325, Exp Date: 2027/08

Quantity recalled: 9384 bottles

Details

Product
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Recalling company
Leading
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Mar 20, 2026
FDA report date
Apr 29, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Furosemide Tablets recalled?
Leading Pharma, LLC recalled Furosemide Tablets in Mar 2026 — an FDA Class II recall (D-0486-2026) because CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Furosemide Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0486-2026 was: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Is a recalled Furosemide Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Furosemide Tablets are affected?
Distributed: US Nationwide.. The recall covers these lots — Lots# H03125, H03225, H03325, Exp Date: 2027/08. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0486-2026.

Source: openFDA Drug Enforcement record D-0486-2026

← All drug recalls